DRDATSONS

Finaventure Capital Limited has submitted to the Exchange vide letter dated April 10, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated April 10, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Datson's Labs Limited vide letter dated March 2, 2015 has submitted the disclosure, under Regulation 13 (3) and (6) of SEBI (Prohibition of Insider Trading) Regulations, 1992, to the Exchange .

Sparrow Asia Diversified opportunities Fund has submitted to the Exchange vide letter dated February 27, 2015 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Leman Diversified Fund has submitted to the Exchange, vide letter dated February 2, 2015 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

SPARROW ASIA DIVERSIFIED OPPORTUNITIES FUND has submitted to the Exchange vide letter dated January 15, 2015 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated January 1, 2015 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Datson's Labs Limited has submitted to the Exchange, vide letter dated December 2, 2014, a copy of the disclosure pursuant to Regulation 13(1), 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated December 02, 2014 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated November 27, 2014 a copy of disclosure pursuant to Regulation 13(1), 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Leman Diversified Fund has submitted to the Exchange, vide letter dated November 26, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Stream Value Fund has submitted to the Exchange, vide letter dated November 26, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated August 12, 2014 a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Stream Value Fund has submitted to the Exchange vide letter dated August 07, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated July 10, 2014 a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Leman Diversified Fund has submitted to the Exchange vide letter dated July 08, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. along with a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Davos International Fund has submitted to the Exchange copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 dated July 04, 2014.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated July 05, 2014 a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated July 01, 2014 a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Davos International Fund has submitted to the Exchange vide letter dated June 30, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Stream Value Fund has submitted to the Exchange vide letter dated June 17, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated June 18, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated June 18, 2014 a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has informed the Exchange regarding disclosures under Regulation 13 (3) and (6)] of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limitedhas submitted to the Exchange vide letter dated May 30, 2014 a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Religare Finvest Limited has submitted to the Exchange, vide letter dated May 29, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Davos International Fund has submitted to the Exchange, vide letter dated May 28, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sparrow Asia Diversified Opportunities Fund has submitted to the Exchange, vide letter dated May 29, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Leman Diversified Fund has submitted to the Exchange, vide letter dated May 29, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Datson's Labs Limitedhas submitted to the Exchange vide letter dated May 29, 2014 a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated May 23, 2014 a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Stream Value Fund has submitted to the Exchange vide letter dated May 22, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(1) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Leman Diversified Fund has submitted to the Exchange vide letter dated May 02, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Sparrow asia Diversified Opportunities Fund has submitted to the Exchange vide letter dated April 29, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Leman Diversified Fund has submitted to the Exchange vide letter dated May 08, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated May 09, 2014 a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Davos International Fund has submitted to the Exchange vide letter dated May 07, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 along with disclosure under regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated May 02, 2014 a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated April 18, 2014 a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Stream Value Fund has submitted to the Exchange vide letter dated April 18, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 along with disclosure under regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Leman Diversified Fund has submitted to the Exchange, vide letter dated April 15, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Davos International Fund has submitted to the Exchange, vide letter dated April 15, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Sparrow Asia Diversified Opportunities Fund has submitted to the Exchange, vide letter dated April 15, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Religare Finvest Limited has submitted to the Exchange vide letter dated April 11 , 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Kuvera Fund Limited has submitted to the Exchange vide letter dated March 26, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange, vide letter dated February 04, 2014 a copy of Disclosures under Regulation 13(4), 13(4A) and 13(6) of Prohibition of Insider Trading Regulation, 1992.

Shree Dhoot Trading & Agencies Ltd, Dome-Bell Electronics India Pvt Ltd, Evans Fraser & Co India Ltd & Nippon Investment & Finance Co. Pvt Ltd has submitted to the Exchange vide letter dated January 29, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated January 230, 2014 a copy of Disclosure under Regulation 13(1), 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange, vide letter dated January 29, 2014 a copy of Disclosures under Reaulatlon 13(6) of Prohibition of Insider Trading Regulation, 1992.

Shree Dhoot Trading And Agencies Limited has submitted to the Exchange vide letter dated January 28, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.